Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2013 March;38(1) > Minerva Endocrinologica 2013 March;38(1):47-58

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  CLINICAL ENDOCRINOLOGY 

Minerva Endocrinologica 2013 March;38(1):47-58

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Bariatric surgery for type 2 diabetes: to whom and when?

Samaras K.

Department of Endocrinology St Vincent’s Hospital, Diabetes and Obesity Group, Garvan Institute of Medical Research, Sydney, Australia


PDF


Achieving clinical and biochemical targets in type 2 diabetes mellitus (diabetes) is fundamental to preventing diabetic microvascular and macrovascular complications. These clinical imperatives are made more challenging in the setting of obesity. This review examines the evidence for bariatric surgery as a means of optimizing diabetes care, addressing diabetes resolution, glucose and lipid metabolism and cardiac effects. Mechanistic evidence of diabetes amelioration is summarized. The question of when bariatric surgery should be offered in the course of obesity-associated diabetes is discussed. Current guidelines and specialist society recommendations for bariatric surgery in diabetes are summarized.

top of page